Moolec Science Income Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Year Ending	TTM	Jun 30, 2023	Jun 30, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	5.01	0.91	0	0	0
Cost of Revenue	4.61	1.05	0	0	0
Gross Profit	0.4	-0.14	0	0	0
Selling, General & Admin	9.15	5.07	2.63	1.72	0.01
Research & Development	1.72	1.35	0.99	0	0
Other Operating Expenses	0.11	3.63	0.04	0	0
Operating Expenses	10.98	10.05	3.65	1.72	0.01
Operating Income	-10.58	-10.19	-3.65	-1.72	-0.01
Interest Expense / Income	0.72	0.16	0	0	0
Other Expense / Income	-3.21	41.67	0.87	-1.62	-
Pretax Income	-8.08	-52.02	-4.53	-0.09	-0.01
Income Tax	-0.56	-0.23	0	0	0
Net Income	-7.52	-51.79	-4.53	-0.09	-0.01
Shares Outstanding (Basic)	38	38	17	17	3
Shares Outstanding (Diluted)	-	-	17	17	3
Shares Change	0.01%	116.24%	2.65%	446.12%	-
EPS (Basic)	-0.16	-1.50	-0.15	-0.01	-
EPS (Diluted)	-0.16	-1.50	-0.15	-0.01	-
Free Cash Flow	-11.09	-7.53	-1.89	-0.92	-0.01
Free Cash Flow Per Share	-0.29	-0.20	-0.11	-0.05	-0.00
Gross Margin	8.01%	-15.83%	-	-	-
Operating Margin	-211.34%	-1125.78%	-	-	-
Profit Margin	-150.28%	-5722.22%	-	-	-
Free Cash Flow Margin	-221.53%	-831.58%	-	-	-
EBITDA	-6.52	-51.74	-4.52	-0.09	-0.01
EBITDA Margin	-130.15%	-5716.97%	-	-	-
Depreciation & Amortization	0.85	0.12	0	0	0
EBIT	-7.37	-51.86	-4.52	-0.09	-0.01
EBIT Margin	-147.15%	-5730.45%	-	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).